SCHEMBL3479726

SCHEMBL3479726

CCCCN(CCO)CCCC.OCC(CO)OB(O)O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5691798 0.82 USP2 (0.37)
Boric Acid SCHEMBL28138844 0.79 ALDH1A1 (0.41) MAPTMAPK1TSHR
Trolamine SCHEMBL11973736 0.77 ALDH1A1 (0.47) MAPTMAPK1TSHR
SCHEMBL43801 0.77 ALDH1A1 (0.47) MAPTMAPK1TSHR
SCHEMBL20629 0.77 ALDH1A1 (0.47) MAPTMAPK1TSHR
Glycerin SCHEMBL3479730 0.77 USP2 (0.35) MAPK1TSHR
SCHEMBL15270583 0.75 ALDH1A1 (0.41) MAPTMAPK1TSHR
SCHEMBL7847234 0.74 ALDH1A1 (0.45) MAPTMAPK1TSHR
SCHEMBL7838829 0.74 ALDH1A1 (0.45) MAPTMAPK1TSHR
Bromide SCHEMBL1835568 0.74 ALDH1A1 (0.45) MAPTMAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1310532-B1 Phase change inks containing borate esters XEROX CORP (US) 2006-05-17 EP claimed
US-6682591-B2 HYDROLYTICALLY STABLE XEROX CORPORATION 2004-01-27 US claimed
US-20030127020-A1 Aqueous ink compositions containing borate esters XEROX CORPORATION 2003-07-10 US claimed
US-6585816-B1 As vehicle for thermal ink jet printing; nonevaporating, nonspilling XEROX CORPORATION 2003-07-01 US claimed
EP-1310532-A1 Phase change inks containing borate esters Xerox Corporation (US) 2003-05-14 EP claimed
US-9028768-B2 Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof AUTERRA, INC. (US) 2015-05-12 US disclosed
US-8877131-B2 Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof AUTERRA, INC. (US) 2014-11-04 US disclosed
US-8262867-B2 Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof AUTERRA, INC. (US) 2012-09-11 US disclosed
EP-2217387-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF Auterra, Inc. (US) 2010-08-18 EP disclosed
US-20100178218-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF AUTERRA, INC. (US) 2010-07-15 US disclosed
US-20100179339-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF AUTERRA, INC. (US) 2010-07-15 US disclosed
US-20100178220-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF AUTERRA, INC. (US) 2010-07-15 US disclosed
WO-2009070420-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF APPLIED NANOWORKS, INC. (US) 2009-06-04 WO disclosed
US-20090134369-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF APPLIED NANOWORKS, INC. (US) 2009-05-28 US disclosed
EP-1310532-B1 Phase change inks containing borate esters XEROX CORP (US) 2006-05-17 EP disclosed
US-6682591-B2 HYDROLYTICALLY STABLE XEROX CORPORATION 2004-01-27 US disclosed
US-20030127020-A1 Aqueous ink compositions containing borate esters XEROX CORPORATION 2003-07-10 US disclosed
US-6585816-B1 As vehicle for thermal ink jet printing; nonevaporating, nonspilling XEROX CORPORATION 2003-07-01 US disclosed
EP-1310532-A1 Phase change inks containing borate esters Xerox Corporation (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179339-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF ADH1A, AKR7A2, PAOX MAPT 3974/4885MAPK1 4372/4885TSHR 1100/4885
US-20090134369-A1 METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF ADH1A, AKR7A2, PAOX MAPT 3974/4885MAPK1 4372/4885TSHR 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.